Ralexar Therapeutics
Advertising Networks · Michigan, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
PO Box 80505, Lansing, Michigan, 48908, ...Website
www.ralexar.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Ralexar Therapeutics
Target-Insyght is a strategic consulting, public opinion, and market research firm that offers a comprehensive range of professional services, including strategic consulting, custom public opinion surveys, actionable focus group research, and campaign consulting. With a team of experienced professionals holding leadership roles across various sectors, the firm is dedicated to delivering results that meet and exceed its clients' expectations. Target-Insyght's clients seek actionable analysis and clear communication of insights, moving beyond mere data presentations to foster effective decision-making. The company aims to assist clients in achieving their goals through expert guidance and support in issues management and advocacy.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ralexar Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Ralexar Therapeutics launches new products
Funding: Get notified immidiatlly once Ralexar Therapeutics has new funding data
Check if Ralexar Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Ralexar Therapeutics
Ralexar Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Ralexar Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Ralexar Therapeutics had a recent Job posting/layoffs
Check out if Ralexar Therapeutics is spiking on competitors!
Recommended Actions
Find VP level buyers at Ralexar Therapeutics
Find more new buyers
Compare Similar Companies to Ralexar Therapeutics
Compare insights from companies similar to Ralexar Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Ralexar Therapeutics
<$5M
11-50
Private
$14.7M
2014
N/A
Company Profile Activity
Activity Insights
Ralexar Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Ralexar Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Ralexar Therapeutics.
Ralexar Therapeutics financials insights
Gather financial insights about Ralexar Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Series A
$10.6M
2017
Private Equity
$4.1M
Ralexar Therapeutics Tech Stack
A closer look at the technologies used by Ralexar Therapeutics
See more technologies
Top Advertising Networks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ralexar Therapeutics
Sign Up For FreeTo access detailed company insights
Target-Insyght is a strategic consulting, public opinion, and market research firm that offers a comprehensive range of professional services, including strategic consulting, custom public opinion surveys, actionable focus group research, and campaign consulting. With a team of experienced professionals holding leadership roles across various secto... Read More
